Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 24932

1.

Reply: DOACs Versus Warfarin in Preventing Myocardial Infarction: Are the Benefits Worth the Price?

Ji-Young Lee C, Torp-Pedersen C.

J Am Coll Cardiol. 2018 Oct 23;72(17):2093-2094. doi: 10.1016/j.jacc.2018.08.2137. No abstract available.

PMID:
30336840
2.

Non-VKA Oral Anticoagulant and Risk of Myocardial Infarction: Paradoxical Procoagulant Effect of Warfarin?

Ye ZL, Guo WQ, Li L.

J Am Coll Cardiol. 2018 Oct 23;72(17):2093. doi: 10.1016/j.jacc.2018.07.091. No abstract available.

PMID:
30336839
3.

DOACs Versus Warfarin in Preventing Myocardial Infarction: Are the Benefits Worth the Price?

Aloia E.

J Am Coll Cardiol. 2018 Oct 23;72(17):2092-2093. doi: 10.1016/j.jacc.2018.07.090. No abstract available.

PMID:
30336838
4.

Reply: Vulnerable Plaques and Vulnerable Patients: The Bright and Dark Side of the Moon.

Min JK.

J Am Coll Cardiol. 2018 Oct 23;72(17):2091-2092. doi: 10.1016/j.jacc.2018.08.2136. No abstract available.

PMID:
30336837
5.

Vulnerable Plaques and Vulnerable Patients: The Bright and Dark Side of the Moon.

Ardissino M.

J Am Coll Cardiol. 2018 Oct 23;72(17):2091. doi: 10.1016/j.jacc.2018.06.079. No abstract available.

PMID:
30336836
6.

Long-Term Trends in Hypertension and Elevated Blood Pressure Among U.S. Adults, 1999 to 2016.

Liu B, Sun Y, Xu G, Rong S, Zhang J, Du Y, Snetselaar LG, Robinson JG, Wallace RB, Bao W.

J Am Coll Cardiol. 2018 Oct 23;72(17):2089-2091. doi: 10.1016/j.jacc.2018.07.086. No abstract available.

PMID:
30336835
7.

Cardiac Outcomes in Pregnant Women With Treated Cancer.

Liu S, Aghel N, Belford L, Silversides CK, Nolan M, Amir E, Maxwell C, Thavendiranathan P.

J Am Coll Cardiol. 2018 Oct 23;72(17):2087-2089. doi: 10.1016/j.jacc.2018.07.085. No abstract available.

PMID:
30336834
8.

Optimal Duration of Dual Antiplatelet Therapy After Left Main Coronary Stenting.

Brener SJ, Serruys PW, Morice MC, Mehran R, Kappetein AP, Sabik JF 3rd, Liu Y, Dressler O, Ben-Yehuda O, Stone GW.

J Am Coll Cardiol. 2018 Oct 23;72(17):2086-2087. doi: 10.1016/j.jacc.2018.07.084. No abstract available.

PMID:
30336833
9.

Impact of Live, Scientific Annual Meetings in Today's Cardiovascular World.

Kates AM, Morris P, Poppas A, Kuvin JT.

J Am Coll Cardiol. 2018 Oct 23;72(17):2082-2085. doi: 10.1016/j.jacc.2018.08.2139.

PMID:
30336832
10.

Inflammation, Immunity, and Infection in Atherothrombosis: JACC Review Topic of the Week.

Libby P, Loscalzo J, Ridker PM, Farkouh ME, Hsue PY, Fuster V, Hasan AA, Amar S.

J Am Coll Cardiol. 2018 Oct 23;72(17):2071-2081. doi: 10.1016/j.jacc.2018.08.1043. Review.

PMID:
30336831
11.

Air Pollution and Cardiovascular Disease: JACC State-of-the-Art Review.

Rajagopalan S, Al-Kindi SG, Brook RD.

J Am Coll Cardiol. 2018 Oct 23;72(17):2054-2070. doi: 10.1016/j.jacc.2018.07.099. Review.

PMID:
30336830
12.

Early Diagnosis of Cardiac Amyloidosis by Carpal Tunnel Surgery: Is it All in the Wrist?

Maurer MS, Ruberg FL.

J Am Coll Cardiol. 2018 Oct 23;72(17):2051-2053. doi: 10.1016/j.jacc.2018.09.003. No abstract available.

PMID:
30336829
13.

Tenosynovial and Cardiac Amyloidosis in Patients Undergoing Carpal Tunnel Release.

Sperry BW, Reyes BA, Ikram A, Donnelly JP, Phelan D, Jaber WA, Shapiro D, Evans PJ, Maschke S, Kilpatrick SE, Tan CD, Rodriguez ER, Monteiro C, Tang WHW, Kelly JW, Seitz WH Jr, Hanna M.

J Am Coll Cardiol. 2018 Oct 23;72(17):2040-2050. doi: 10.1016/j.jacc.2018.07.092.

PMID:
30336828
14.

Should All Atrial Fibrillation Be Considered a Life-Long Problem Requiring Prophylaxis Against Thromboembolism?

Curtis AB, Khan HA.

J Am Coll Cardiol. 2018 Oct 23;72(17):2037-2039. doi: 10.1016/j.jacc.2018.07.087. No abstract available.

PMID:
30336827
15.

Risk of Thromboembolism Associated With Atrial Fibrillation Following Noncardiac Surgery.

Butt JH, Olesen JB, Havers-Borgersen E, Gundlund A, Andersson C, Gislason GH, Torp-Pedersen C, Køber L, Fosbøl EL.

J Am Coll Cardiol. 2018 Oct 23;72(17):2027-2036. doi: 10.1016/j.jacc.2018.07.088.

PMID:
30336826
16.

Vulnerable Plaques, Vulnerable Patients, and Intravascular Imaging.

Stone GW, Mintz GS, Virmani R.

J Am Coll Cardiol. 2018 Oct 23;72(17):2022-2026. doi: 10.1016/j.jacc.2018.09.010. No abstract available.

PMID:
30336825
17.

Effect of Evolocumab on Coronary Plaque Composition.

Nicholls SJ, Puri R, Anderson T, Ballantyne CM, Cho L, Kastelein JJP, Koenig W, Somaratne R, Kassahun H, Yang J, Wasserman SM, Honda S, Shishikura D, Scherer DJ, Borgman M, Brennan DM, Wolski K, Nissen SE.

J Am Coll Cardiol. 2018 Oct 23;72(17):2012-2021. doi: 10.1016/j.jacc.2018.06.078.

PMID:
30336824
18.

Prognostic Value of Intravascular Ultrasound in Patients With Coronary Artery Disease.

Schuurman AS, Vroegindewey MM, Kardys I, Oemrawsingh RM, Garcia-Garcia HM, van Geuns RJ, Regar E, Van Mieghem NM, Ligthart J, Serruys PW, Boersma E, Akkerhuis KM.

J Am Coll Cardiol. 2018 Oct 23;72(17):2003-2011. doi: 10.1016/j.jacc.2018.08.2140.

PMID:
30336823
19.

Percutaneous Coronary Intervention in Acute Coronary Syndrome: Completing the Job Saves Lives.

Mahmud E, Ben-Yehuda O.

J Am Coll Cardiol. 2018 Oct 23;72(17):2000-2002. doi: 10.1016/j.jacc.2018.08.2129. No abstract available.

PMID:
30336822
20.

Complete Versus Culprit-Only Lesion Intervention in Patients With Acute Coronary Syndromes.

Rathod KS, Koganti S, Jain AK, Astroulakis Z, Lim P, Rakhit R, Kalra SS, Dalby MC, O'Mahony C, Malik IS, Knight CJ, Mathur A, Redwood S, Sirker A, MacCarthy PA, Smith EJ, Wragg A, Jones DA.

J Am Coll Cardiol. 2018 Oct 23;72(17):1989-1999. doi: 10.1016/j.jacc.2018.07.089.

PMID:
30336821

Supplemental Content

Loading ...
Support Center